These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 27521848)

  • 1. Chloroquine inhibits lytic replication of Kaposi's sarcoma-associated herpesvirus by disrupting mTOR and p38-MAPK activation.
    Yang M; Huang L; Li X; Kuang E
    Antiviral Res; 2016 Sep; 133():223-33. PubMed ID: 27521848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation.
    Huang L; Yang M; Yuan Y; Li X; Kuang E
    Antiviral Res; 2017 Feb; 138():68-78. PubMed ID: 27939840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of the Human Kinome Identifies MSK1/2-CREB1 as an Essential Pathway Mediating Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication during Primary Infection.
    Cheng F; Sawant TV; Lan K; Lu C; Jung JU; Gao SJ
    J Virol; 2015 Sep; 89(18):9262-80. PubMed ID: 26109721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
    Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
    J Virol; 2017 May; 91(10):. PubMed ID: 28275189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib Inhibits the Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK.
    Chen J; Jiang L; Lan K; Chen X
    Viruses; 2015 May; 7(5):2268-87. PubMed ID: 25951487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an ORF45-Derived Peptide To Inhibit the Sustained RSK Activation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
    Li X; Huang L; Xiao Y; Yao X; Long X; Zhu F; Kuang E
    J Virol; 2019 May; 93(10):. PubMed ID: 30842327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5'-AMP-Activated Protein Kinase.
    Cheng F; He M; Jung JU; Lu C; Gao SJ
    J Virol; 2016 Jul; 90(14):6515-6525. PubMed ID: 27147746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's sarcoma-associated herpesvirus: the role of lytic replication in targeted therapy.
    Andrei G; Snoeck R
    Curr Opin Infect Dis; 2015 Dec; 28(6):611-24. PubMed ID: 26524334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DNase Activity of Kaposi's Sarcoma-Associated Herpesvirus SOX Protein Serves an Important Role in Viral Genome Processing during Lytic Replication.
    Uppal T; Meyer D; Agarwal A; Verma SC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.
    Xie J; Ajibade AO; Ye F; Kuhne K; Gao SJ
    Virology; 2008 Feb; 371(1):139-54. PubMed ID: 17964626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation.
    Chen J; Dai L; Goldstein A; Zhang H; Tang W; Forrest JC; Post SR; Chen X; Qin Z
    PLoS Pathog; 2019 Dec; 15(12):e1008156. PubMed ID: 31790497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Kaposi's sarcoma-associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen-activated protein kinase pathways during primary infection.
    Pan H; Xie J; Ye F; Gao SJ
    J Virol; 2006 Jun; 80(11):5371-82. PubMed ID: 16699017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
    Purushothaman P; Thakker S; Verma SC
    J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.
    Xu D; Coleman T; Zhang J; Fagot A; Kotalik C; Zhao L; Trivedi P; Jones C; Zhang L
    J Virol; 2007 Jun; 81(11):6068-78. PubMed ID: 17376914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hesperetin inhibits KSHV reactivation and is reversed by HIF1α overexpression.
    Long WY; Zhao GH; Wu Y
    J Gen Virol; 2021 Nov; 102(11):. PubMed ID: 34747688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
    Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
    J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KSHV targeted therapy: an update on inhibitors of viral lytic replication.
    Coen N; Duraffour S; Snoeck R; Andrei G
    Viruses; 2014 Nov; 6(11):4731-59. PubMed ID: 25421895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
    Jiang Y; Xu D; Zhao Y; Zhang L
    PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin blocks production of KSHV/HHV8: insights into the anti-tumor activity of an immunosuppressant drug.
    Nichols LA; Adang LA; Kedes DH
    PLoS One; 2011 Jan; 6(1):e14535. PubMed ID: 21264294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids.
    Gorres KL; Daigle D; Mohanram S; Miller G
    J Virol; 2014 Jul; 88(14):8028-44. PubMed ID: 24807711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.